Role of Center for Cancer Genomics and Advanced Therapeutics (C-CAT) in health insurance system
2022 Volume 59 Issue 1 Pages 1-6
Details
2022 Volume 59 Issue 1 Pages 1-6
On the basis of the report of Expert Meeting for the Cancer Genomic Medicine Promotion Consortium released in June 2017, the core hospitals for cancer genomic medicine have been designated. In addition, the Center for Cancer Genomics and Advanced Therapeutics (C-CAT) was established within the National Cancer Center. In June 2019, comprehensive genome profiling tests covered by the national health insurance system were started in Japan. By October 2021, more than 20,000 cases have been registered, and cancer genomic medicine is progressing steadily. In August 2021, comprehensive genome profiling tests of blood samples were also covered by the Health Care Insurance of Japan, and the number of tests is expected to increase further in the future. From October 2021, the utilization of the cancer genome real world data accumulated in C-CAT in research was started.
